Inventor · disambiguated record
Martin Johansson
Also filed as: JOHANSSON MARTIN · JOHANSSON MARTIN H · JOHANSSON MARTIN HANS
14 granted patents·18 pending applications·48 citations·filing 2003–2022
86Inventor score
Top patents by PatentIndex Score
32 records- 0193US7585881B2Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Sep 8, 2009·36 cites·2 claims
- 0282US7456200B2CompoundsASTRAZENECA AB·Filed 2005·Granted Nov 25, 2008·9 cites·11 claims
- 0372US7576077B2Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 0464US11957772B2Petrolatum substitution preparationAAK AB PUBL·Filed 2021·Granted Apr 16, 2024·0 cites·44 claims
- 0562US2007293545A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0662US2008015204A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0762US2008045571A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0862US2008015234A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0961US8754086B2Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancerPERSSON JENNY·Filed 2010·Granted Jun 17, 2014·1 cites·17 claims
- 1060US2023202982A15-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-quinoline-3-carboxamide potassium salt for treating inflammatory bowel diseasesAQILION AB·Filed 2021·Application pending·0 cites
- 1159US2023167064A1Treatments of inflammatory bowel diseaseAQILION AB·Filed 2021·Application pending·0 cites
- 1258US2019298626A1Petrolatum substitution preparationAAK AB PUBL·Filed 2017·Application pending·0 cites
- 1357US2007179188A1Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 1456US2011021540A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1556US2009281138A1Bis-(Sulfonylamino) Derivatives in Therapy 066ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1654US2024279233A1Macrocyclic tak1 inhibitorsAQILION AB·Filed 2022·Application pending·0 cites
- 1749US10538500B2Tricyclic prodrugsGLACTONE PHARMA DEV AB·Filed 2018·Granted Jan 21, 2020·0 cites·13 claims
- 1849US9066947B2Indolyl-substituted pyrazino[1,2-b]isoquinolines for cancer treatmentEVEREST BIOSCIENCES INC·Filed 2014·Granted Jun 30, 2015·0 cites·21 claims
- 1949US7691892B2Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Apr 6, 2010·0 cites·22 claims
- 2048US2006019997A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2148US2007185178A1Triazole compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2248US2007197549A1Tetrazole compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2348US2009131468A1Bis-(Sulfonylamino) Derivatives in Therapy 065ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2445US2004152699A1CompoundsASTRAZENECA AND NPS PHARMACEUT·Filed 2003·Application pending·0 cites
- 2542US2005004130A1New metabotropic glutamate receptor compoundsASTRAZENECA AND NPS PHARMACEUT·Filed 2004·Application pending·0 cites
- 2640US2007185095A1Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2739US10781197B2Sulfonamide analogues of galiellalactoneGLACTONE PHARMA DEV AB·Filed 2017·Granted Sep 22, 2020·0 cites·19 claims
- 2839US10077246B2Tricyclic prodrugsGLACTONE PHARMA DEV AB·Filed 2015·Granted Sep 18, 2018·0 cites·15 claims
- 2934US11680054B2Bronchodilating hetero-linked amidesARCEDE PHARMA AB·Filed 2019·Granted Jun 20, 2023·0 cites·20 claims
- 3034US8318768B2Bronchodilating alpha, beta-unsaturated isoquinoline amidesDALENCE MARIA·Filed 2008·Granted Nov 27, 2012·0 cites·25 claims
- 3125US8415333B2Bronchodilating diazaheteroarylsJOHANSSON MARTIN·Filed 2010·Granted Apr 9, 2013·0 cites·17 claims
- 3223US9150531B2Tricyclic lactones for treatment of cancerGIDLÖF Ritha·Filed 2011·Granted Oct 6, 2015·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Martin Johansson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →